4
Changes in Ownership
NEOGENOMICS INC Filed Acc 0001077183-19-000020
VP and Chief Culture Officer sold 44,000 shares at an average $19.42 ($854,360)
- VP and Chief Culture Officer acquired 44,000 shares (option exercise)
- VP and Chief Culture Officer acquired 2,862 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BALLIET JENNIFER · VP and Chief Culture Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-28 | Exercise or conversion : show line 1 in the form | +20,000 | $7.52 | $150,400 | 40,000 | D |
| 2019-02-28 | Exercise or conversion : show line 2 in the form | +10,000 | $8.03 | $80,300 | 50,000 | D |
| 2019-02-28 | Sale : show line 3 in the form | −30,000 | $19.57 | $587,100 | 20,000 | D |
| 2019-03-01 | Grant or award : show line 4 in the form | +2,862 | 22,862 | D | ||
| 2019-03-04 | Exercise or conversion : show line 5 in the form | +14,000 | $8.03 | $112,420 | 36,862 | D |
| 2019-03-04 | Sale : show line 6 in the form | −14,000 | $19.09 | $267,260 | 22,862 | D |
| Open-market sales · 44,000 sh · avg $19.42 · $854,360 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2019-02-28 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −10,000 | $8.03 | 2023-02-26 | 10,000 | 62,500 | D | ||
| 2019-02-28 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −20,000 | $7.52 | 2022-04-28 | 20,000 | 40,000 | D | ||
| 2019-03-01 | Grant or award : show line 9 in the form Stock Option (Right to Buy) | +17,496 | $19.60 | $342,922 | $19.60 | 2024-03-01 | 17,496 | 17,496 | D |
| 2019-03-04 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −14,000 | $8.03 | 2023-02-26 | 14,000 | 48,500 | D |
Loading xslF345X03/wf-form4_155173830561711.xml…